Related references
Note: Only part of the references are listed.A Mixed Micellar Formulation for the Transdermal Delivery of an Indirubin Analog
Seol Hwa Seo et al.
PHARMACEUTICS (2020)
Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis-associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects
Mitsuhiro Kawakubo et al.
SCIENTIFIC REPORTS (2020)
Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
Jean-Francois Dufour et al.
GUT (2020)
STELLAR 3 and STELLAR 4: Lessons from the fall of Icarus
Mary E. Rinella et al.
JOURNAL OF HEPATOLOGY (2020)
Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression
Minyoung Lee et al.
SCIENTIFIC REPORTS (2020)
Lgr5+ pericentral hepatocytes are self-maintained in normal liver regeneration and susceptible to hepatocarcinogenesis
Chow Hiang Ang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Sven Francque et al.
ADVANCES IN THERAPY (2019)
CXXC5 mediates growth plate senescence and is a target for enhancement of longitudinal bone growth
Sehee Choi et al.
LIFE SCIENCE ALLIANCE (2019)
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
Rohit Loomba et al.
HEPATOLOGY (2018)
Current and future pharmacological therapies for NAFLD/NASH
Yoshio Sumida et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Therapies in non-alcoholic steatohepatitis (NASH)
Abdul M. Oseini et al.
LIVER INTERNATIONAL (2017)
Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β
Kevin M. Hart et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Inhibition of Glycogen Synthase Kinase 3 Accelerated Liver Regeneration after Acetaminophen-Induced Hepatotoxicity in Mice
Bharat Bhushan et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
Andrea Marengo et al.
ANNUAL REVIEW OF MEDICINE, VOL 67 (2016)
Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma
Ana L. Gomes et al.
CANCER CELL (2016)
Small molecule inhibitors of the Dishevelled-CXXC5 interaction are new drug candidates for bone anabolic osteoporosis therapy
Hyun-Yi Kim et al.
EMBO MOLECULAR MEDICINE (2016)
Exenatide Improves Both Hepatic and Adipose Tissue Insulin Resistance: A Dynamic Positron Emission Tomography Study
Amalia Gastaldelli et al.
HEPATOLOGY (2016)
CXXC5 is a negative-feedback regulator of the Wnt/β-catenin pathway involved in osteoblast differentiation
H-Y Kim et al.
CELL DEATH AND DIFFERENTIATION (2015)
Current efforts and trends in the treatment of NASH
Vlad Ratziu et al.
JOURNAL OF HEPATOLOGY (2015)
Hepatic progenitor cells of biliary origin with liver repopulation capacity
Wei-Yu Lu et al.
NATURE CELL BIOLOGY (2015)
Adipose tissue browning and metabolic health
Alexander Bartelt et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
Jonathan E. Campbell et al.
CELL METABOLISM (2013)
A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice
Norihiro Kubota et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2013)
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar et al.
GASTROENTEROLOGY (2013)
In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration
Meritxell Huch et al.
NATURE (2013)
Morphogens and hepatic stellate cell fate regulation in chronic liver disease
Hidekazu Tsukamoto et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Inflammatory Mechanisms in Obesity
Margaret F. Gregor et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
A novel and comprehensive mouse model of human non-alcoholic steatohepatitis with the full range of dysmetabolic and histological abnormalities induced by gold thioglucose and a high-fat diet
Mitsunari Ogasawara et al.
LIVER INTERNATIONAL (2011)
Wnt signalling and the control of cellular metabolism
Jaswinder K. Sethi et al.
BIOCHEMICAL JOURNAL (2010)
Lgr5+ve Stem Cells Drive Self-Renewal in the Stomach and Build Long-Lived Gastric Units In Vitro
Nick Barker et al.
CELL STEM CELL (2010)
WNT signalling is both an inducer and effector of glucagon-like peptide-1 - Commentary
B. Gustafson et al.
DIABETOLOGIA (2008)
Lgr5 marks cycling, yet long-lived, hair follicle stem cells
Viljar Jaks et al.
NATURE GENETICS (2008)
PPARδ as a therapeutic target in metabolic disease
Shannon M. Reilly et al.
FEBS LETTERS (2008)
Wnt/β-catenin signaling in murine hepatic transit amplifying progenitor cells
Min Hu et al.
GASTROENTEROLOGY (2007)
Identification of stem cells in small intestine and colon by marker gene Lgr5
Nick Barker et al.
NATURE (2007)
Biology of incretins: GLP-1 and GIP
Laurie L. Baggio et al.
GASTROENTEROLOGY (2007)
Abdominal obesity and metabolic syndrome
Jean-Pierre Despres et al.
NATURE (2006)
Inflammation and metabolic disorders
Goekhan S. Hotamisligil
NATURE (2006)
Nonalcoholic fatty liver disease - A feature of the metabolic syndrome
G Marchesini et al.
DIABETES (2001)
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
AJ Sanyal et al.
GASTROENTEROLOGY (2001)
Share Paper
